GlassScriptPhysician profile
Mateen Ahmed
NPI 1922028604
$14,946.14
in general payments reported to CMS, 2019-2025
22 companies · $2,202 in 2025
The $2,202 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $254 · 2021: $179 · 2022: $119 · 2023: $6,889 · 2024: $5,038 · 2025: $2,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,442 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,037.38 |
| Food and Beverage | $1,442.12 |
| Travel and Lodging | $650.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,786.82 | 2023-2025 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $785.61 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Mylan Specialty L.P. | $263.04 | 2023-2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $150.99 | 2020-2025 | Breztri, Airsupra |
| Sunovion Pharmaceuticals INC. | $118.32 | 2019-2020 | |
| Viatris Specialty LLC | $110.85 | 2025 | Yupelri |
| Erbe USA INC | $100.00 | 2025 | Erbecryo2 |
| Galvanize Therapeutics, INC | $97.81 | 2025 | Aliya System |
| Insmed, INC. | $97.55 | 2024-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $75.30 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $74.65 | 2024-2025 | Prolastin-C Liquid |
| Amgen INC. | $56.90 | 2024-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $45.79 | 2024 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $26.46 | 2019-2021 | |
| Tempus Ai, INC | $23.10 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $22.99 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Daiichi Sankyo INC. | $22.58 | 2024 | Enhertu |
| Verona Pharma, INC. | $22.53 | 2025 | Ohtuvayre |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Genzyme Corporation | $16.56 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Merck Sharp & Dohme LLC | $13.39 | 2024 | Zerbaxa, Recarbrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mateen Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.